Emergent BioSolutions Ownership | Who Owns Emergent BioSolutions?


OverviewForecastRevenueFinancialsChartTranscripts

Emergent BioSolutions Ownership Summary


Emergent BioSolutions is owned by 73.11% institutional investors, 2.86% insiders, and 24.03% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.05% of EBS shares. Avantis US Small Cap Value ETF is the top mutual fund, with 3.60% of its assets in Emergent BioSolutions shares.

EBS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEmergent BioSolutions73.11%2.86%24.03%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustrySpecialty & Generic Drug Manufacturers Stocks43.51%11.55%44.95%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de4.36M8.05%$27.82M
Blackrock3.84M7.36%$26.18M
Oak hill advisors lp3.61M6.67%$10.94M
Vanguard group3.20M6.03%$30.60M
Millennium management2.50M4.60%$12.16M
American century companies2.29M4.23%$14.62M
State street1.96M3.70%$18.77M
Invesco1.54M2.90%$14.72M
Charles schwab investment management1.29M2.43%$12.33M
Morgan stanley1.24M2.38%$8.47M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Oak hill advisors lp3.61M2.74%$10.94M
Values first advisors376.00K1.31%$2.40M
Kent lake capital300.00K0.92%$2.05M
Prescott group capital management772.77K0.58%$4.93M
Morse asset management158.82K0.35%$1.52M
Palisade capital management, lp1.10M0.20%$7.02M
Hussman strategic advisors105.00K0.15%$669.90K
Entrypoint capital43.22K0.14%$275.74K
Whitebox advisors500.00K0.10%$3.41M
Contrarian capital management40.00K0.09%$272.80K

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de4.36M0.00%2.53M
Oak hill advisors lp3.61M2.74%2.50M
Millennium management2.50M0.01%1.02M
Invesco1.54M0.00%639.00K
Goldman sachs group969.07K0.00%521.22K

Top Sellers

HolderShares% AssetsChange
Blackrock3.84M0.00%-3.22M
Avidity partners management lp---1.91M
Charles schwab investment management1.29M0.00%-934.50K
Qube research346.93K0.00%-740.41K
Aqr capital management460.31K0.00%-591.39K

New Positions

HolderShares% AssetsChangeValue
Whitebox advisors500.00K0.10%500.00K$3.41M
Kent lake capital300.00K0.92%300.00K$2.05M
Man group176.78K0.00%176.78K$1.69M
Wolverine asset management136.33K0.01%136.33K$1.30M
Gsa capital partners llp51.27K0.04%51.27K$490.00K

Sold Out

HolderChange
Frazier financial advisors-2.00
Federation des caisses desjardins du quebec-4.00
Financial gravity asset management-9.00
Nelson, van denburg & campbell wealth management group-10.00
Nisa investment advisors-30.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20251723.61%39,625,9449.49%731.65%10012.36%35-12.50%
Mar 31, 20254-97.58%3,665,317-89.44%60.16%1-98.77%2-94.87%
Dec 31, 20241606.67%34,658,9219.38%651.83%7821.88%38-24.00%
Sep 30, 20241495.67%31,651,6794.07%591.78%64-21.95%5042.86%
Jun 30, 202413910.32%30,408,059-15.80%581.22%8053.85%35-22.22%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Avantis US Small Cap Value ETF1.92M3.60%-
Vanguard US Total Market Shares ETF1.64M3.01%-
Vanguard Total Stock Mkt Idx Inv1.57M2.95%-34.94K
iShares Russell 2000 ETF1.28M2.40%-24.36K
SPDR® S&P Biotech ETF944.09K1.74%23.32K
Invesco FTSE RAFI US 1500 Small-Mid ETF917.91K1.69%-
Palisade Small Cap Core Equity690.44K1.27%-30.60K
Vanguard Institutional Extnd Mkt Idx Tr589.25K1.10%-257.68K
Schwab Fundamental U.S. Small CompanyETF536.56K1.01%-
Invesco RAFI US 1500 Small-Mid ETF540.39K1.00%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 15, 2025Zoon Kathryn C-Sell$62.85K
Aug 12, 2025DeGolyer Donald W-Sell$67.83K
May 23, 2025Katkin Keith-Sell$49.42K
May 13, 2025PAPA JOSEPH C President and CEOBuy$349.80K
Mar 12, 2025Fowler Neal Franklin-Sell$204.05K

Insider Transactions Trends


DateBuySell
2025 Q3-1
2025 Q211
2025 Q1-2
2024 Q4-2
2024 Q3--

EBS Ownership FAQ


Who Owns Emergent BioSolutions?

Emergent BioSolutions shareholders are primarily institutional investors at 73.11%, followed by 2.86% insiders and 24.03% retail investors. The average institutional ownership in Emergent BioSolutions's industry, Specialty & Generic Drug Manufacturers Stocks, is 43.51%, which Emergent BioSolutions exceeds.

Who owns the most shares of Emergent BioSolutions?

Emergent BioSolutions’s largest shareholders are Blackrock funding, inc. /de (4.36M shares, 8.05%), Blackrock (3.84M shares, 7.36%), and Oak hill advisors lp (3.61M shares, 6.67%). Together, they hold 22.07% of Emergent BioSolutions’s total shares outstanding.

Does Blackrock own Emergent BioSolutions?

Yes, BlackRock owns 7.36% of Emergent BioSolutions, totaling 3.84M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.18M$. In the last quarter, BlackRock decreased its holdings by -3.221M shares, a -45.62% change.

Who is Emergent BioSolutions’s biggest shareholder by percentage of total assets invested?

Oak hill advisors lp is Emergent BioSolutions’s biggest shareholder by percentage of total assets invested, with 2.74% of its assets in 3.61M Emergent BioSolutions shares, valued at 10.94M$.

Who is the top mutual fund holder of Emergent BioSolutions shares?

Avantis US Small Cap Value ETF is the top mutual fund holder of Emergent BioSolutions shares, with 3.60% of its total shares outstanding invested in 1.92M Emergent BioSolutions shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools